TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial. March 1, 2002